Subscribe
Sign In
Tag: CBT > Preclinical Medical Cannabis Research
Cannabis Industry Research
The Man Behind DEA’s Federal Marijuana Scam
DEA Senior Policy Adviser Matthew Strait defied presidential mandates for medical research, MMJ International Holdings claims.
January 28, 2025
Industry Headlines
Attorney General, DEA Director, Judge Under Federal Court Summons Over DEA Marijuana Policy
Despite the DEA’s policy, MMJ International is moving forward with the FDA on cannabis drug development for Huntington’s disease.
January 6, 2025
Industry Headlines
DEA Continues to Block MMJ Marijuana Drug Development for Neurological Disorder
MMJ submitted an FDA Investigational New Drug application for a cannabis-derived medication.
December 11, 2024
Industry Headlines
FDA Clears MAPS Researchers to Proceed With Cannabis Study for Veterans With PTSD
The Multidisciplinary Association for Psychedelic Studies (MAPS) researchers negotiated with the FDA for three years.
November 22, 2024
Industry Headlines
‘Sleepy’ Cannabis: Study to Show Cannabinol (CBN) Increases Sleep
The non-hallucinogenic marijuana constituent increases sleep in rats.
November 12, 2024
Cannabis Industry Research
Medical Marijuana Act Signed by Biden Would Hinder Research Under Rescheduling
The Medical Marijuana and Cannabidiol Research Expansion Act’s requirements would remain under Schedule III, a congressional researcher says.
September 20, 2024
Industry Headlines
MMJ BioPharma Suing DEA Over Cannabis Reform, Medical Research
The biopharmaceutical company filed a lawsuit, citing ‘unjustified’ delays in processing an application for medical research.
September 11, 2024
Cannabis Industry Research
Raphael Pharmaceutical Issues Letter to Shareholders
The letter highlights the company’s exclusive relationship with Rambam Health Care Campus, differentiated cannabinoid-based technology platform, promising lead product candidate for rheumatoid arthritis, recently commenced clinical study, broader pipeline opportunities, and overall mission and vision.
July 9, 2024
Cannabis Industry Research
Cannabis Company Sues DEA Over Application to Grow for Clinical Trials
Rhode Island-based MMJ BioPharma Cultivation Inc. is seeking an order to halt the DEA’s ‘unconstitutional actions’ as it awaits approval to grow cannabis.
April 8, 2024
Compliance
Federally Approved Cannabis?
Pennsylvania-based Groff North America has begun growing DEA-approved cannabis for FDA clinical trials.
March 9, 2022
International
Flora Growth Pursues Research on Cannabinoid-Based COVID-19 Treatment in Colombia
The cultivation company wants to research its patent-pending treatment to gauge “all the potential mechanisms of cannabinoids in preventing infection from the SARS-CoV-2 (COVID-19) virus.”
February 7, 2022
Hemp Research
Preliminary Studies Show Cannabinoids Could Ward Off COVID-19. Will They Live Up to Their Potential?
Recent research from several universities highlights the promise of cannabinoids in fighting off coronavirus through various phases of infection, but experts warn the studies are still too preliminary to draw conclusions.
January 24, 2022
Page 1 of 2
Next Page